- Home
- VLTO vs PODD Comparison
VLTO vs PODD Comparison
Compare VLTO & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLTO
- PODD
- Stock Information
- Founded
- VLTO 2023
- PODD 2000
- Country
- VLTO United States
- PODD United States
- Employees
- VLTO N/A
- PODD N/A
- Industry
- VLTO Electrical Products
- PODD Medical/Dental Instruments
- Sector
- VLTO Industrials
- PODD Health Care
- Exchange
- VLTO Nasdaq
- PODD Nasdaq
- Market Cap
- VLTO 26.0B
- PODD 22.1B
- IPO Year
- VLTO N/A
- PODD 2007
- Fundamental
- Price
- VLTO $99.70
- PODD $314.03
- Analyst Decision
- VLTO Buy
- PODD Strong Buy
- Analyst Count
- VLTO 7
- PODD 19
- Target Price
- VLTO $116.67
- PODD $338.79
- AVG Volume (30 Days)
- VLTO 1.4M
- PODD 441.1K
- Earning Date
- VLTO 10-28-2025
- PODD 11-06-2025
- Dividend Yield
- VLTO 0.44%
- PODD N/A
- EPS Growth
- VLTO 12.64
- PODD N/A
- EPS
- VLTO 3.65
- PODD 3.32
- Revenue
- VLTO $5,452,000,000.00
- PODD $2,359,500,000.00
- Revenue This Year
- VLTO $8.01
- PODD $29.27
- Revenue Next Year
- VLTO $5.49
- PODD $18.30
- P/E Ratio
- VLTO $27.30
- PODD $96.38
- Revenue Growth
- VLTO 6.15
- PODD 26.00
- 52 Week Low
- VLTO $83.87
- PODD $230.05
- 52 Week High
- VLTO $110.11
- PODD $353.50
- Technical
- Relative Strength Index (RSI)
- VLTO 36.39
- PODD 42.32
- Support Level
- VLTO $97.16
- PODD $309.27
- Resistance Level
- VLTO $105.75
- PODD $322.86
- Average True Range (ATR)
- VLTO 1.90
- PODD 7.15
- MACD
- VLTO -0.33
- PODD -0.70
- Stochastic Oscillator
- VLTO 37.99
- PODD 8.40
About VLTO Veralto Corp
Veralto is a diversified industrial firm organized into two segments, water quality as well as product quality and innovation. The water quality segment offers water analytics and water treatment solutions, while the product quality and innovation segment offers coding, packaging, and color solutions for consumer packaged goods and pharmaceuticals. Headquartered in Waltham, Massachusetts, the company has around 17,000 employees. Veralto generated approximately $5.2 billion in revenue in 2024.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.